You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Claims for Patent: 7,858,789


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,858,789
Title:Derivatives of 4-aminopiperidine and their use as a medicament
Abstract:A subject of the present application is new derivatives of 4-aminopiperidines of formula in which R1, R2 and R3 represent various radical, and their preparation processes by synthetic methods in parallel in liquid and solid phase. These products having a good affinity with certain sub-types of somatostatin receptors, they are particularly useful for treating the pathological states or diseases in which one (or more) somatostatin receptors are involved.
Inventor(s):Christophe Thurieau, Jérôme Gonzalez, Christophe Moinet
Assignee:Ipsen Pharma SAS
Application Number:US12/151,115
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,858,789
Patent Claims: 1. Compounds of the general formula: in racemic, enantiomeric form or all combinations of these forms, in which: R1 represents a —(CH2)m—Z12 radical in which Z12 represents optionally substituted aryl; R2 represents a radical of formula —C(Y)NHX1, wherein X1 represents a (CH2)p—Z22 radical in which Z22 represents aryl optionally substituted; R3 represents an optionally substituted alkyl; Y represents an oxygen or a sulphur atom; m is an integer from 1 to 6; and p is an integer from 0 to 6; or their addition salts with pharmaceutically acceptable mineral or organic acids.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.